Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LFMD LifeMD, Inc. Common Stock
$2.12 1.92% +0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LFMD stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

LifeMD, Inc. Common Stock (LFMD)

Loading

Key Stats

Market cap. 102.3M
Enterprise value 83.5M
Trailing PE 8.5200004577637
Forward PE 5.4736843
PEG Ratio 0.051120002746582
Enterprise to EBITDA -4.407
Enterprise to revenue 0.436
Price to book MRQ 12.45509
Price to sales TTM 0.5238835

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 191.6M
EBITDA -18955210
Diluted EPS TTM -0.51
Total Cash (MRQ) 25.1M
Current ratio (MRQ) 0.903
Operating Cash Flow (TTM) -6691737

LFMD trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LFMD News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.